chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 4/5/2023 Discharge Date: 4/10/2023  PRESENTING PROBLEM: Respiratory infection Sepsis due to pneumonia Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID Sepsis   HOSPITAL COURSE:    Patient is a 61 y.o. male with prior medical history of progressive MS, chronic pain, depression, GERD, OSA who presented to hospital on 4/5/2023 with progressive weakness and fatigue.  The patient was found to be have Sepsis and COVID-19 positive upon arrival to the emergency department.  Initial chest x-ray performed in the emergency department showed concern for right axillary mass however CT of the chest did not visualize in the right axillary mass or lymph node enlargement.  Was noted to have mild left and right basilar streaky ground-glass opacities.  He received an initial dose of azithromycin and ceftriaxone and was monitored off for 24 hours.  Due to no leukocytosis or elevation of procalcitonin.  The patient then developed elevated fevers and an elevated procalcitonin and leukocytosis on 04/07/2023 and the antibiotics were resumed due to post-viral community acquired pneumonia.  While hospitalized he completed a 5 day course of azithromycin and ceftriaxone.  He also received 5 days of remdesivir. He will be discharging home with continued home health care services.  Discharge doing with the Mucinex as well as p.r.n. albuterol inhaler.  Due to myalgias he was also given a 3 day script for Norco as this has been helping with the symptom control.  Recommend post hospitalization follow-up with PCP in 1 week.
Tingling/numbness starting mid chest, and spreading upwards and over head, including face and scalp.  Reoccurence of facial numbness experienced with 1st J&J dose from April 3rd, 2021. Initial brief dizziness while sitting  Tingling diminished over the course of 15-20 minutes, moved into Right Lateral Hand.   Experienced Transient chest tightness with onset of chest numbness No itching and no hives  7 months post vaccine, still some residual intermittent facial numbness on left corner of mouth(same side as reaction from J&J) even though opposite arm injected
Sore throat, congestion, headache, shortness of breath, fatigue.  Self test for Covid19 was positive. Consulted physician. Received prescription. Within about 5 days symptoms were mostly resolved.
Fever 102. Decreased interaction, increased hyperactivity. Decreased eye contact, walking back into mom (never happened before). Plugging ears to tune out people/sound. Overall regression.
Patient developed a site reaction at the injection site on the left upper arm.  Induration, warmth, redness and itching.  She also developed a hive type rash on the bilateral inner thighs that was highly pruritic.  Patient was advised to use ice on the arm.  To take Claritin in the am x 7 days, Zyrtec in pm x 7 days and Benadryl needed per package instructions.  Advised patient to not finish the series of vaccinations.
irritability, high pitched screams x hrs, inc sleeping then ok late 2nd day; On 3rd day seen by MD-hospitalized w/sepsis; w/u ? viral mengitis;
While receiving the vaccine, I immediately had a rush of a strong metallic taste in my mouth. I equally had a metallic odor in my nose.  Within 5 minutes of receiving the vaccine, I experienced flushing and a headache (only on the left side of my head.)  My arm at the injection site grew progressively painful (I did not have any redness or bruising at the site.)   The headache subsided after approximately 20 minutes; the flushing went away within a couple of hours of receiving the vaccine.   Several hours after receiving the vaccine, I developed some minor itching. My arm continued to hurt more at the injection site (I never developed any redness or bruising at the site.) I experienced body aches and general malaise (as I was informed was to be expected.)  I continued to have the strong metallic taste in my mouth into the evening and nighttime hours following the vaccine. During the night (approximately 9 hours after receiving the vaccine,) I awoke to an unfamiliar odor, and feeling nauseous.  The odor was emitted from my skin.   It has been approximately  72 hours since I received the Pfizer COVID  vaccine. The skin odor and metallic state have lessened, but are still persistent.
Patient received his flu vaccine on 12/17/2021. A few days later, patient's legs started feeling tired. This feeling progressed over the next few weeks and his legs began feeling very heavy. Patient also started experiencing fatigue, unsteady gait, head and neck pain all prior to an appointment with his primary care on 2/17/2022. Patient's PCP started ordering x-rays, MRI?s and CT Scans to determine what was going on with Patient's gait. On 3/19/2022, patient feel to the ground after becoming paralyzed from the waist down. His wife took him to ER after being in contact with Doctors there regarding patients symptoms. Patient was admitted to hospital where he underwent several tests to diagnose him with MOG and days of treatment to follow which included plasmapheresis and high dose steroids. Patient was able to walk at the end of this 10 day stay and discharged to an inpatient rehab for a week. Patient was doing okay until June when he again became paralyzed and was taken back to ER and again admitted to hospital for another 10 days of testing and treatment. Patient was doing well again at the end of this stay and discharged to outpatient rehab. The following month, Patient had severe head and neck pain and was taken to the local hospital. He was then transferred to hospital where he was admitted back to hospital this time for a month due to complications with inpatient rehab following. Patient has been paralyzed from the waist down since June 25th and continues outpatient rehab.
COVID-19; COVID-19; Interchange of vaccine products; This is a spontaneous report received from a non-contactable reporter(s) (Consumer). The reporter is the patient. A 48-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Sep2022 as dose 4 (booster), single (Lot number: gh9694) at the age of 47 years, in left arm for COVID-19 immunization; BNT162b2 (BNT162B2), on 29Mar2021 as dose 1, single (Lot number: er8732), in left arm and on 26Apr2021 as dose 2, single (Lot number: ew0171), in left arm for COVID-19 immunization; elasomeran (MODERNA COVID-19 VACCINE), on 29Nov2021 as dose 3 (booster), single (Lot number: 058h21a), in left arm for COVID-19 immunization. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: treated; "hypothyroidism" (unspecified if ongoing), notes: treated; "Known allergies: sulfa" (unspecified if ongoing). The patient took concomitant medications (treatment for high blood pressure and hypothyroidism). Past drug history included: Codeine, reaction(s): "Known allergies".  The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 29Nov2021, outcome "unknown"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Mar2023, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of vaccination failure and covid-19 with PAXLOVID from 08Mar2023 until 12Mar2023.   No follow-up attempts are possible. No further information is expected.
Pt noticed slight swelling on left bicep a few hours after the pneumovax was administered. The vaccine was given in the left deltoid. Pt denies any pain, afebrile 98.1 F.
pain, redness, swelling at injection site, muscle pain, tiredness, headache, shivering, fever, upset stomach, tightness in chest, itching, burning and mild rash on arm of injection.  Symptoms lasted 2 days except the arm itching, burning, rash lasted 4 days
This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (Diarrhea), DIZZINESS (Dizzy when walking), RHINORRHEA (Runny Nose), CHILLS (Chills) and MYALGIA (Aches all over the body) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced DIARRHEA (Diarrhea), DIZZINESS (Dizzy when walking), RHINORRHEA (Runny Nose), CHILLS (Chills) and MYALGIA (Aches all over the body). At the time of the report, DIARRHEA (Diarrhea), DIZZINESS (Dizzy when walking), RHINORRHEA (Runny Nose), CHILLS (Chills) and MYALGIA (Aches all over the body) outcome was unknown. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Polymerase chain reaction: negative (Negative) Negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient visited the hospital emergency response (ER). It was reported that all tests were normal. Concomitant medications and treatment information were not provided.
Psychological disorder; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation; ziprasidone (ZIPRASIDONE) (Batch/Lot number: unknown). The patient's relevant medical history and concomitant medications were not reported.The following information was reported: MENTAL DISORDER (non-serious), outcome "unknown", described as "Psychological disorder". The action taken for ziprasidone was unknown.  Additional information: The patient stated that "I'm placing to threaten Pfizer, that's my psychological disorder" (Misplaced comment).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Diarrhea; Headache; Nauseous; Second dose was administered before 19 days of primary dose; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Jun2021 at 16:00 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25May2021 at 16:00 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. On 09Jun2021, the patient experienced diarrhea, headache and nauseous. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, headache and nauseous was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PT CAME IN ONE WEEK AFTER VACCINE, AND INFORMED RN THAT HE HAD HAD A REACTION TO THE VACCINE, SHOWED RN SITE, SITE WAS RED, AND HAD A 1/2 INCH BY 1/4 INCH SCABBED OVER WOUND WITH APPROXIMATELY 1 TO 1 AND HALF INCH REDNESS SURROUNDING WOUND.  PT ALSO COMPLAINED OF MUSCULAR PAIN, IN ABILITY TO LIFT ARM AND TINGLING AND PAIN DOWN TO HAND.   PT WAS SEEN BY MD AND CALLED BACK IN 1 WEEK, AT THAT TIME ONLY HAD PAIN AT THE SITE AND WOUND ALMOST HEALED.  ADMINISTERED BY STUDENT RN OBSERVED BY INSTRUCTOR.
p/vax pt devel fever to 101.5 then fever to 101-102 x 3 days;pt less active slept more, hard to rouse, personality change & did not smile, nursed less each time-ill for 3 days;fever 101.5;local swelling DTP site;
little bit of bleeding, like menses, vaginal bleeding; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient's husband). A 35-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced a little bit of bleeding, like menses, vaginal bleeding. Patient had bleeding the following night, after the first dose. The outcome of the event was unknown.  Additional information has been requested and will be provided as it becomes available.
is having some stomach pain; I am having some discomfort in my stomach and I am taking Prilosec; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 28Apr2021 (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ABDOMINAL PAIN UPPER (non-serious), outcome "unknown", described as "is having some stomach pain"; ABDOMINAL DISCOMFORT (non-serious), outcome "unknown", described as "I am having some discomfort in my stomach and I am taking Prilosec". Therapeutic measures were taken as a result of abdominal pain upper, abdominal discomfort.  Additional information: Caller is due to get her booster dose and she is taking Prilosec and is having some stomach pain, wants to know if she can get the booster. She is asking if it's safe to get the Covid-19 vaccine booster while also taking Prilosec but she did state that she is already on the medication for 5 days. So, while after her first and second dose of the Covid-19 Vaccine. Consumer stated, I already had the original shot the last one was 28Apr. So, I am a candidate for the booster but at this moment I am having some discomfort in my stomach and I am taking Prilosec and I am wondering if it's safe to be the booster.  Follow-up (PRD 09Nov2021/SRD 10Nov2021): This is a follow-up spontaneous report from a Pfizer sponsored program. A contactable female consumer (patient) reported for herself included: Updated information: Clinical information.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Follow-up (15Dec2021)This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
black and blue marks towards the pad of the finger/Her whole finger except for a little bit in the front is black and blue and moving to the next joint; formed a bruise on the pinky finger/her whole finger except for a little bit in the front is black and blue and moving to the next joint; This is a spontaneous report from a contactable nurse.  A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 22Mar2021 13:35 (Batch/Lot Number: EN6208) as dose 1, single (at the age of 64 years old) for COVID-19 immunisation.  Medical history included Left Hip Replacement from 23Feb2021 (she had a total hip replacement and she has been taking Aspirin 81mg twice a day), Breast Cancer with Lymph Node Removal; Right; she can't have anything in the right arm because she is a breast cancer survivor and had lymph nodes removed) and taken aspirin-started to prevent blood clots. Concomitant medications included acetylsalicylic acid (ASPIRIN 81) taken for anticoagulant/ started to prevent blood clots from 23Feb2021.  The patient experienced she had a strange reaction and she did not know if it is due to the Pfizer covid 19 vaccine. Last night (24Mar2021) at 8:30 pm she formed a bruise on the pinky finger on the side that she got the vaccine in. She had black and blue marks towards the pad of the finger. This morning, the purple went to the whole pad and throughout the day it has extended to the other side of her finger on the outside and moving down the inside of her finger below the nail, not underneath the fingernail, and across like it is trying to meet in the front. Stated that on the outside it has now covered the whole line, covering the entire pad and side of the finger and now on the top. Her whole finger except for a little bit in the front is black and blue and moving to the next joint. Patient wanted to know if this was due to the aspirin. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Recieved first dose on 19Jan2021, recieved second dose of moderna covid-19 vaccine; Recieved first dose on 19Jan2021, recieved second dose of moderna covid-19 vaccine; take pfizer for a booster; wide awake; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. Other Case identifier(s) MOD21-164358 (Moderna). A 78-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 13Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included Bladder infection (unspecified if ongoing); Triglycerides (unspecified if ongoing). Concomitant medication(s) included FIBRATE taken for blood triglycerides. Vaccination history included Moderna covid-19 vaccine (First dose, Expiration date: 03Jul2021, Received the vaccine in the left upper arm), administration date: 19Jan2021, when the patient was 78 years old, for COVID-19 Immunization; Moderna covid-19 vaccine (Second dose, Lot number: 024M20A, Expiration date: 03Aug2021, Received the vaccine in the left upper arm), administration date: 15Feb2021, when the patient was 78 years old, for COVID-19 Immunization. The following information was reported OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 13Nov2021, outcome unknown; IMMUNISATION (non-serious) with onset 13Nov2021, outcome unknown; INSOMNIA (non-serious) with onset Nov2021, outcome unknown. Therapeutic measures were taken as a result of insomnia.  Patient reports she was afraid to get the Moderna COVID-19 booster because she didn't want to go through that again. Her sister suggested take Pfizer for a booster, so received Pfizer 13Nov2021, and was again wide awake. Not sure if going to last. Plans to call Pfizer. Safety follow-up consent provided for patient and HCP. There was no product complaint associated with this case. Patient was not pregnant at the time of vaccination.   No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report received from a consumer concerned a 64 year old female of unspecified race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously treated with Covid-19 vaccine ad26.cov2.s (dose number in series:1) (suspension for injection, intramuscular, batch number and expiry date not reported) dose was not reported, 1 total administered on 01-MAR-2021 for prophylactic vaccination. The patient experienced headache and sinus disorder when treated with Covid-19 vaccine ad26.cov2.s (dose number in series: 1). The patient received Covid-19 vaccine ad26.cov2.s (dose number in series: 2) (suspension for injection, intramuscular, batch number and expiry date not reported) dose was not reported, 1 total administered (off label use, and inappropriate schedule of vaccine administered) on 01-OCT-2021 for prophylactic vaccination.(dose number in series: 2).The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Non-company suspect drugs included: adalimumab (solution for injection in pre-filled pen, subcutaneous, batch number was not reported) dose and frequency were not reported from an unspecified date to JAN-2022 for psoriasis. No concomitant medications were reported. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable; and action taken with adalimumab was not reported. The outcome of the off label use and inappropriate schedule of vaccine administered was not reported. This report was non-serious. This case, involving the same patient is linked to 20220228734.
Shaking and grunting onset 30 mins. Cyanotic coloring head, hands, feet, lips and tongue. Heart rate too rapid to count. Audible respirations. Tremors with some spastic movements. Grabs fingers with good grip O2 at 2L blowby color began to pink up- good copillary refill 911 call ER.
Fever of 102, body chills, nausea, headache, body aches, pain in lower back/kidneys, frequent nighttime urination. Headache and body/ kidney aches persisted until 1pm the following day, chills, fever frequent urination, nausea persisted until 7am the following day.
Severe hip joint and back pain, vomiting, high fever, headache, extreme fatigue all lasting 4 days. I was not able to take care of myself.   I had two such reactions after the first dose and two following the second dose with a 24 hour bout with milder symptoms as the third after the second dose. It comes on with no warning and lasts from 3-4 days.
Headache; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients. This is the second of two reports.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 10Jan2021 at a single dose for COVID-19 immunization. The patient's medical history concomitant medications were not reported. The patient took the Pfizer COVID at (Hospital name) on 10Jan2021 and experienced a headache immediately and that went away. The outcome of the event was recovered on 10Jan2021.  Information on the Batch/Lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021026386 same reporter/drug/event, different patient.
I received my shingles vaccination from my pharmacist at pharmacy on Wednesday, June 14th, 2017. On Thursday, June 15, 2017, I began experiencing redness, a hard lump at the injection site and warmth on my left arm. I applied ice all day and took MOTRIN, thinking that the discomfort would subside. Instead, the rash grew larger and the lump under the skin became the size of a tangerine and by Friday morning the skin had blistered. I have been prescribed AUGMENTIN for the acute cellulitis that occurred due to this vaccination.
About a month after getting the second moderna dose,  I began having hives,  which was  new to my health.  Hives were never an issue previously.  They are almost 24/7 now.  Break outs have occurred almost everywhere on body.
Within 24 hours experienced headache, fever, tiredness & soreness at injection site,  but then developed a rash, redness & pain approximately 4 inches down from injection site  & similar to what I experienced when I had shingles 5 years ago.  It extended across the muscle approximately 6 inches & down the arm 4-5".  Pain went away by day 4, but redness remained for approximately 2 weeks until it disappeared.